Clinical evidence on PET/CT for radiation therapy planning in prostate cancer

Radiotherapy and Oncology

Volumn 96, Issue 3, 2010, Pages 347-350

  Picchio, Maria ^a,b   Giovannini, Elisabetta ^a   Crivellaro, Cinzia ^b   Gianolli, Luigi ^a   Muzio, Nadia Di ^a   Messa, Cristina ^b,c,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c CNR   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

Author keywords

Choline; PET; Prostate; Recurrence

Indexed keywords

CHOLINE C 11;

CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; HUMAN; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956186794     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.07.016     Document Type: Review

References (44)

1. M. Pinkawa, C. Attieh, and M.D. Piroth Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost Radiother Oncol 93 2009 213 219
2. C.T. Muijs, L.M. Schreurs, and D.M. Busz Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer Radiother Oncol 93 2009 447 453
3. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
4. D. Pucar, T. Sella, and H. Schoder The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery Curr Opin Urol 18 2008 87 97
5. A.L. Grosu, M. Piert, and W.A. Weber Positron emission tomography for radiation treatment planning Strahlenther Onkol 181 2005 483 499
6. A. Senft, R. de Bree, and O.S. Hoekstra Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial Radiother Oncol 87 2008 221 229
7. P.D. Shreve, H.B. Grossman, M.D. Gross, and R.L. Wahl Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-d-glucose Radiology 199 1996 751 756
8. J.A. Richter, M. Rodriguez, and J. Rioja Dual tracer (11)C-Choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment Mol Imaging Biol 12 2010 210 217
9. S.A. Muller, K. Holzapfel, and C. Seidl Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment Eur J Nucl Med Mol Imaging 36 2009 1434 1442
10. M. Picchio, C. Messa, and C. Landoni Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography J Urol 169 2003 1337 1340
11. V. Scattoni, M. Picchio, and N. Suardi Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423 429
12. G. Giovacchini, M. Picchio, and E. Coradeschi Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy Eur J Nucl Med Mol Imaging 37 2010 301 309
13. B.J. Krause, M. Souvatzoglou, and M. Tuncel The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 18 23
14. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80
15. Heidenreich A, Bolla M, Joniau S, et al. Guidelines on Prostate Cancer. European Association of Urology; 2010. http://www.uroweb.org/guidelines/online- guidelines/.
16. G. Groenendaal, M.R. Moman, and J.G. Korporaal Validation of functional imaging with pathology for tumor delineation in the prostate Radiother Oncol 94 2010 145 150
17. M.G. Harisinghani, J. Barentsz, and P.F. Hahn Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491 2499
18. R.A. Heesakkers, J.J. Futterer, and A.M. Hovels Prostate cancer evaluated with ferumoxtran-10-enhanced T2-weighted MR Imaging at 1.5 and 3.0 T: early experience Radiology 239 2006 481 487
19. G. Giovacchini, M. Picchio, and E. Coradeschi [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumor stage and anti-androgenic therapy Eur J Nucl Med Mol Imaging 35 2008 1065 1073
20. R. Schiavina, V. Scattoni, and P. Castellucci 11C-Choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms Eur Urol 54 2008 392 401
21. W. Luboldt, R. Kufer, and N. Blumstein Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases Radiology 249 2008 1017 1025
22. M. Picchio, C. Crivellaro, G. Giovacchini, L. Gianolli, and C. Messa PET-CT for treatment planning in prostate cancer Q J Nucl Med Mol Imaging 53 2009 245 268
23. G. Martorana, R. Schiavina, and A. Franceschelli Should we perform imaging-guided lymph- node dissection in patients with lymphatic recurrence of prostate cancer after radical prostatectomy? Eur Urol 55 2009 1302 1304
24. J.L. Peterson, S.J. Buskirk, and M.G. Heckman Late toxicity after postprostatectomy salvage radiation therapy Radiother Oncol 93 2009 203 206
25. L.E. Kershaw, J.P. Logue, C.E. Hutchinson, N.W. Clarke, and D.L. Buckley Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging Radiother Oncol 88 2008 127 134
26. S.N. Reske, N.M. Blumstein, and G. Glatting [11C]Choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy Eur J Nucl Med Mol Imaging 35 2008 9 17
27. I.J. de Jong, J. Pruim, P.H. Elsinga, W. Vaalburg, and H.J. Mensink 11C-Choline positron emission tomography for the evaluation after treatment of localized prostate cancer Eur Urol 44 2003 32 38 [discussion 8-9]
28. L. Rinnab, F.M. Mottaghy, and N.M. Blumstein Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer BJU Int 100 2007 786 793
29. P. Castellucci, C. Fuccio, and C. Nanni Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy J Nucl Med 50 2009 1394 1400
30. A.J. Breeuwsma, J. Pruim, and A.C. van den Bergh Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography Int J Radiat Oncol Biol Phys 77 2010 160 164
31. B.A. Jereczek-Fossa, A. Kowalczyk, and A. D'Onofrio Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients Strahlenther Onkol 184 2008 36 40
32. H. Van Poppel Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy? Eur Urol 55 2009 1012 1013
33. M. Picchio, F. Alongi, and G. Giovacchini 11C-Choline PET/CT image-guided radiotherapic treatment of lymph nodal recurrence in prostate cancer patients Eur J Nucl Med Mol Imaging 35 2008 388
34. M. Picchio, F. Alongi, and G. Giovacchini 11C-Choline PET/CT image-guided tomotherapy treatment of lymph nodal relapse in prostate cancer patients J Nucl Med 51 2010 1274
35. M. Farsad, R. Schiavina, and P. Castellucci Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis J Nucl Med 46 2005 1642 1649
36. S.N. Reske, N.M. Blumstein, and B. Neumaier Imaging prostate cancer with 11C-choline PET/CT J Nucl Med 47 2006 1249 1254
37. S. Yoshida, K. Nakagomi, S. Goto, M. Futatsubashi, and T. Torizuka 11C-Choline positron emission tomography in prostate cancer: primary staging and recurrent site staging Urol Int 74 2005 214 220
38. L. Rinnab, J. Simon, and R.E. Hautmann [(11)C]Choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy World J Urol 27 2009 619 625
39. D.B. Husarik, R. Miralbell, and M. Dubs Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 253 263
40. D.C. Weber, H. Wang, and L. Cozzi RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study Radiat Oncol 4 2009 34
41. S. Albrecht, F. Buchegger, and D. Soloviev (11)C-Acetate PET in the early evaluation of prostate cancer recurrence Eur J Nucl Med Mol Imaging 34 2007 185 196
42. H. Vees, F. Buchegger, and S. Albrecht 18F-Choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy BJU Int 99 2007 1415 1420
43. J. Kotzerke, B.G. Volkmer, and G. Glatting Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer Nuklearmedizin 42 2003 25 30
44. J. Seppala, M. Seppanen, E. Arponen, P. Lindholm, and H. Minn Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer Radiother Oncol 93 2009 234 240